The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ZYME FINANCIAL STATEMENTS

Zymeworks Inc. Common Stock — balance sheet, income statement and cash flow trends

ZYMEZymeworks Inc. Common Stock

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0200 M400 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue37.1 M $Gross Profit32.6 M $ · 88%Operating Income-155.6 M $ · -419%Pre-tax Income-151.4 M $ · -408%Net Income to Owners-150 M $ · -404%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue37.1 M $-69.8%
Gross Profit32.6 M $-73.5%
Operating Income-155.6 M $—
EBITDA-139.9 M $—
Net Income to Owners-150 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets397 M
  • Equity80.4 M $20%
  • Current Liabilities47.2 M $12%
  • Long-term Liabilities269.4 M $68%

Key Figures

YoY change
Total Assets397 M $-2.8%
Total Liabilities316.6 M $+328.5%
Total Equity80.4 M $-76.0%
Cash & ST Investments270.7 M $-3.8%
Total Debt268.6 M $+1,338.3%
Net Debt89.2 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M0200 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M0-119.1 M $Operating92.5 M $Investing107.5 M $Financing81 M $Net Change

Key Figures

YoY change
Operating Cash Flow-119.1 M $—
Capital Expenditures1.4 M $-44.4%
Free Cash Flow-120 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ZYME

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.